On this page: Current list | Deletions
For further details, visit the High-Cost Drugs Policy — Section 5.8, PharmaCare Policy Manual
An asterisk (*) indicates the most recent addition(s). Deletions are listed at the end.
DIN/PIN |
Chemical Description |
Product Name |
Allowable Markup |
Effective Date |
---|---|---|---|---|
02506009 | ozanimod hydrochloride, 0.23 mg and 0.46 mg oral capsules (7-day starter-pack) | Zeposia® | 5% | Jan 16, 2024 |
02505991 | ozanimod hydrochloride, 0.92 mg oral capsule | Zeposia® | 5% | Jan 16, 2024 |
02402475 |
abatacept subcutaneous 125 mg/mL pre-filled syringe (PFS) |
Orencia® |
5% |
Apr 1, 2014 |
02282097 |
abatacept 250 mg vial |
Orencia® |
5% |
Apr 1, 2011 |
02528363 |
abrocitinib 50 mg tablet |
Cibinqo® |
5% |
Nov 28, 2023 |
02528371 |
abrocitinib 100 mg tablet |
Cibinqo® |
5% |
Nov 28, 2023 |
02528398 |
abrocitinib 200 mg tablet |
Cibinqo® |
5% |
Nov 28, 2023 |
02542358 | adalimumab 80 mg/0.8 mL PFS | Hyrimoz® | 5% | July 3, 2024 |
02542366 | adalimumab 80 mg/0.8 mL autoinjector | Hyrimoz® | 5% | July 3, 2024 |
02542323 | adalimumab 40 mg/0.4 mL PFS | Hyrimoz® | 5% | July 3, 2024 |
02542331 | adalimumab 40 mg/0.4 mL autoinjector | Hyrimoz® | 5% | July 3, 2024 |
02542315 | adalimumab 20 mg/0.2 mL PFS | Hyrimoz® | 5% | July 3, 2024 |
02511061* |
adalimumab 20 mg/0.4 mL PFS |
Abrilada™ |
5% |
Aug 18, 2022 |
02533472 | adalimumab 40 mg/0.4 mL PFS | Hadlima® | 5% | Dec 19, 2023 |
02533480 | adalimumab 40 mg/0.4 mL autoinjector | Hadlima® PushTouch® | 5% | Dec 19, 2023 |
02535076 | adalimumab 80 mg/0.8 mL PFS | Yulflyma™ | 5% | Dec 19, 2023 |
02535084 | adalimumab 80 mg/0.8 mL autoinjector | Yulflyma™ | 5% | Dec 19, 2023 |
02529548 | tezepelumab 210 mg/1.91 mL PFS | Tezspire™ | 5% | Dec 19, 2023 |
02529556 | tezepelumab 210 mg/1.91 mL autoinjector | Tezspire™ | 5% | Dec 19, 2023 |
02511053* | adalimumab 40 mg/0.8 mL PFS | Abrilada™ | 5% | Aug 18, 2022 |
02511045* | adalimumab 40 mg/0.8 mL pen | Abrilada™ | 5% | Aug 18, 2022 |
02459310 |
adalimumab 20 mg/0.4 mL syringe |
Amgevita™ |
5% |
Apr 7, 2021 |
02459299 | adalimumab 40 mg/0.8 mL syringe | Amgevita™ | 5% | Apr 7, 2021 |
02459302 | adalimumab 40 mg/0.8 mL autoinjector | Amgevita™ | 5% | Apr 7, 2021 |
02473097 |
adalimumab 40 mg/0.8 mL syringe |
Hadlima® |
5% |
Apr 7, 2021 |
02473100 | adalimumab 40 mg/0.8 mL autoinjector | Hadlima® | 5% | Apr 7, 2021 |
02502380* |
adalimumab 20 mg/0.4 mL PFS |
Hulio® |
5% |
Aug 18, 2022 |
02502399 | adalimumab 40 mg/0.8 mL syringe | Hulio® | 5% | Apr 7, 2021 |
02502402 | adalimumab 40 mg/0.8 mL pen | Hulio® | 5% | Apr 7, 2021 |
02258595 |
adalimumab 40 mg/0.8 mL kit |
Humira® |
5% |
Apr 1, 2011 |
02505258 |
adalimumab 20 mg/0.4 mL PFS |
Hyrimoz® |
5% |
Apr 7, 2021 |
02492156 | adalimumab 40 mg/0.8 mL autoinjector | Hyrimoz® | 5% | Apr 7, 2021 |
02492164 | adalimumab 40 mg/0.8 mL PFS | Hyrimoz® | 5% | Apr 7, 2021 |
02502674 |
adalimumab 40 mg/0.8 mL pen |
Idacio® |
5% |
Apr 7, 2021 |
02502682 |
adalimumab 40 mg/0.8 mL PFS |
Idacio® |
5% |
Oct 1, 2021 |
|
100 mg/mL high-dose formulation: |
Simlandi™ |
5% |
Aug 18, 2022 |
|
100 mg/mL high-dose formulation: |
Yuflyma® |
5% |
Aug 18, 2022 |
02418320 |
alemtuzumab 10 mg/mL (1.2 mL) concentrated solution for IV infusion |
Lemtrada® |
5% |
Apr 12, 2018 |
02204606 |
alpha 1-proteinase inhibitor 1000 mg vial |
Prolastin-C® |
5% |
Apr 1, 2011 |
02307065 |
ambrisentan 5 mg tablet |
Volibris® |
5% |
Apr 2, 2012 |
02307073 |
ambrisentan 10 mg tablet |
Volibris® |
5% |
Apr 2, 2012 |
02503034 |
amifampridine 10 mg |
Ruzurgi® |
5% |
May 10, 2023 |
02245913 |
anakinra 100 mg/0.67 mL syringe |
Kineret® |
5% |
Apr 1, 2011 |
02329840 |
aztreonam 75 mg/vial powder for solution |
Cayston™ |
5% |
Sep 13, 2012 |
02131064 |
baclofen 2 mg/mL ampule |
Lioresal® |
5% |
Apr 1, 2011 |
02473232 |
benralizumab 30 mg/mL in 1 mL syringe |
Fasenra® |
5% |
Apr 1, 2020 |
02496135 |
benralizumab 30 mg/mL autoinjector pen |
Fasenra® |
5% |
Apr 28, 2021 |
02525267 |
bimekizumab, 160mg/mL pre-filled syringe |
Bimzelx® |
5% |
Jan 31, 2023 |
02525275 |
bimekizumab, 160mg/mL autoinjector |
Bimzelx® |
5% |
Jan 31, 2023 |
02244981 |
bosentan 62.5 mg tablet |
Tracleer® |
5% |
Apr 1, 2011 |
02244982 |
bosentan 125 mg tablet |
Tracleer® |
5% |
Apr 1, 2011 |
02531577 |
botulinum toxin 50 unit vial |
Botox® |
5% |
Apr 1, 2011 |
02324032 |
botulinum toxin 100 unit vial |
Xeomin® |
5% |
Apr 1, 2011 |
02266121 |
cannabidiol/tetrahydrocannabinol 2.5 mg/2.7 mg per mL spray |
Sativex® |
5% |
Apr 2, 2012 |
02465574 |
certolizumab pegol 200 mg/mL auto-injector pre-filled pen |
Cimzia® |
5% |
Feb 1, 2018 |
02331675 |
certolizumab pegol 400 mg/2 mL syringe kit |
Cimzia® |
5% |
Apr 1, 2011 |
02244849 |
colistimethate sodium 150 mg vial |
Colistimethate® |
5% |
Apr 1, 2011 |
00476420 |
colistimethate sodium 150 mg vial |
Coly-Mycin® |
5% |
Apr 1, 2015 |
02485605 |
cysteamine ophthalmic solution 0.37% |
Cystadrops® |
0% |
Feb 28, 2022 |
02452219 |
deferasirox 90 mg tablet |
Jadenu® |
5% |
Oct 26, 2017 |
02452227 |
deferasirox 180 mg tablet |
Jadenu® |
5% |
Oct 26, 2017 |
02452235 |
deferasirox 360 mg tablet |
Jadenu® |
5% |
Oct 26, 2017 |
02287447 |
deferasirox 500 mg tablet for suspension |
Exjade® |
5% |
Apr 1, 2011 |
02436558 |
deferiprone 1000 mg tablet |
Ferriprox® |
5% |
Jan 18, 2017 |
02436523 |
deferiprone 100 mg/mL oral solution |
Ferriprox® |
5% |
Jan 18, 2017 |
02404508 |
dimethyl fumarate 120 mg capsule |
Tecfidera® |
5% |
Dec 15, 2014 |
02420201 |
dimethyl fumarate 240 mg capsule |
Tecfidera® |
5% |
Dec 15, 2014 |
0249504 |
dupilumab 200mg/1.14 mL pre-filled syringe |
Dupixent® |
5% |
Nov 23, 2023 |
02470365 |
dupilumab 300mg/2 mL pre-filled syringe |
Dupixent® |
5% |
Nov 23, 2023 |
02510049 |
dupilumab 300mg/2 mL single-dose pre-filled pen |
Dupixent® |
5% |
Nov 23, 2023 |
0252452 |
dupilumab 200mg/1.14 mL single-dose pre-filled pen |
Dupixent® |
5% |
Nov 23, 2023 |
02475472 |
edaravone 30 mg/100 mL solution for intravenous use |
Radicava® |
0% |
Aug 19, 2020 |
02532611 |
edaravone oral suspension 105 mg/5 mL |
Radicava ORS® |
0% |
Aug 18, 2023 |
02517140 | elexacaftor 100mg/tezacaftor 50mg/ivacaftor 75mg and ivacaftor 150mg oral tablets | Trikafta® | 0% | Oct 5, 2021 |
02526670 | elexacaftor 50 mg/tezacaftor 25 mg/ivacaftor 37.5mg and ivacaftor 75mg oral tablets | Trikafta® | 0% | Oct 5, 2021 |
02542277 | elexacaftor 100mg/tezacaftor 50mg/ivacaftor 75mg and ivacaftor 75mg oral granules | Trikafta® | 0% | Dec 14, 2023 |
02542285 | elexacaftor 80mg/tezacaftor 40mg/ivacaftor 60mg and ivacaftor 59.5mg oral granules | Trikafta® | 0% | Dec 14, 2023 |
02397447 |
epoprostenol sodium (arginine) 0.5 mg vial |
Caripul |
5% |
Dec 22, 2014 |
02397455 |
epoprostenol sodium (arginine) 1.5 mg vial |
Caripul |
5% |
Dec 22, 2014 |
02230848 |
epoprostenol sodium 1.5 mg vial |
Flolan® |
5% |
Apr 1, 2011 |
02242903 |
etanercept 25 mg kit |
Enbrel® |
5% |
Apr 1, 2011 |
02274728 |
etanercept 50 mg/mL syringe |
Enbrel® |
5% |
Apr 1, 2011 |
01968017 |
filgrastim 300 mcg/mL vial |
Neupogen® |
5% |
Apr 1, 2011 |
02365480 |
fingolimod 0.5 mg capsule |
Gilenya® |
5% |
Jun 13, 2013 |
02537702 |
foslevodopa-foscarbidopa | Vyalev™ | 5% | August 20, 2024 |
02245619 |
glatiramer acetate 20 mg kit |
Copaxone® |
5% |
Apr 1, 2011 |
02467550 |
glecaprevir-pibrentasvir 100mg-40 mg tablet |
Maviret™ |
2% |
Mar 21, 2019 |
02522470 |
glecaprevir-pibrentasivir 50 mg-40 mg oral granules in sachet | Maviret™ | 2% | August 20, 2024 |
02453304 |
glycerol phenylbutyrate 1.1 g/mL oral liquid |
Ravicti™ |
5% |
Apr 12, 2018 |
02324776 |
golimumab 50 mg/0.5 mL pre-filled syringe |
Simponi® |
5% |
Apr 1, 2011 |
02324784 |
golimumab 50 mg/0.5 mL auto-injector |
Simponi® |
5% |
Apr 1, 2011 |
02146118 |
hydromorphone 20 mg/mL vial |
Dilaudid-HP-Plus® |
5% |
Apr 1, 2011 |
02145936 |
hydromorphone 20 mg/mL vial |
Hydromorphone HP 20® |
5% |
Apr 2, 2012 |
02145863 |
hydromorphone 50 mg/mL vial |
Dilaudid-XP® |
5% |
Apr 2, 2012 |
02146126 |
hydromorphone 50 mg/mL vial |
Hydromorphone HP 50® |
5% |
Apr 1, 2011 |
02241751 |
imiglucerase 400 unit vial |
Cerezyme® |
5% |
Apr 1, 2011 |
02371081 |
incobotulinumtoxinA (also known as |
Xeomin® |
5% |
Apr 1, 2014 |
02496933 |
infliximab 100 mg vial |
Avsola™ |
5% |
Apr 1, 2021 |
02419475 |
infliximab 100 mg vial |
Inflectra™ |
5% |
Apr 1, 2016 |
02470373 |
infliximab 100 mg vial |
Renflexis™ |
5% |
Nov 3, 2018 |
02244016 |
infliximab 100 mg vial |
Remicade® |
5% |
Apr 1, 2011 |
02237770 |
interferon beta-1a 30 mcg /mL kit |
Avonex® |
5% |
Apr 2, 2012 |
02269201 |
interferon beta-1a 30 mcg /0.5 mL kit |
Avonex® PS |
5% |
Apr 1, 2011 |
02281708 |
interferon beta-1a 8.8 mcg/0.2 mL - 22 mcg/0.5 mL syringe initiation pack |
Rebif® |
5% |
Apr 2, 2012 |
02237319 |
interferon beta-1a 22 mcg/0.5 mL syringe |
Rebif® |
5% |
Apr 1, 2011 |
02237320 |
interferon beta-1a 44 mcg/0.5 mL syringe |
Rebif® |
5% |
Apr 1, 2011 |
02318253 |
interferon beta-1a 66 mcg/1.5 mL cartridge |
Rebif® |
5% |
Apr 1, 2011 |
02318261 |
interferon beta-1a 132 mcg/1.5 mL cartridge |
Rebif® |
5% |
Apr 1, 2011 |
02169649 |
interferon beta-1b 0.3 mg vial |
Betaseron® |
5% |
Apr 1, 2011 |
02337819 |
interferon beta-1b 0.3 mg vial |
Extavia® |
5% |
Apr 1, 2011 |
02455102 |
ixekizumab 80 mg/mL autoinjector |
Taltz™ |
5% |
Mar 6, 2018 |
02455110 |
ixekizumab 80 mg/mL pre-filled syringe |
Taltz™ |
5% |
Mar 6, 2018 |
02432226 |
ledipasvir/sofosbuvir 90 mg-400 mg tablet |
Harvoni® |
2% |
Mar 1, 2017 |
02469375 |
letermovir 240 mg tablet |
Prevymis™ |
5% |
May 18, 2021 |
02469383 |
letermovir 480 mg tablet |
Prevymis™ |
5% |
May 18, 2021 |
02292165 |
levodopa/carbidopa intestinal gel 20 mg/mL – 5 mg/mL |
Duodopa® |
5% |
Aug 24, 2017 |
02505541 |
luspatercept 25 mg vial |
Reblozyl® |
5% |
March 14, 2023 |
02505568 |
luspatercept 75 mg vial |
Reblozyl® |
5% |
March 14, 2023 |
02449781 |
mepolizumab 100 mg/mL vial of lyophilized powder for subcutaneous injection |
Nucala |
5% |
Nov 13, 2018 |
02492989 |
mepolizumab 100 mg/mL pre-filled autoinjector |
Nucala |
5% |
May 26, 2020 |
02492997 |
mepolizumab 100 mg/mL pre-filled safety syringe |
Nucala |
5% |
May 26, 2020 |
02286386 |
natalizumab 300 mg/15 mL vial |
Tysabri® |
5% |
Apr 2, 2012 |
02325926 |
nimodipine 30 mg tablet |
Nimotop® |
5% |
Apr 2, 2012 |
02443066 |
nintedanib 100 mg tablet |
Ofev™ |
5% |
Apr 12, 2018 |
02443074 |
nintedanib 150 mg tablet |
Ofev™ |
5% |
Apr 12, 2018 |
02458616 |
nitisinone 2 mg tablet |
Nitisinone Tablets |
5% |
Jan 1, 2021 |
02457717 |
nitisinone 2 mg capsule |
MDK-Nitisinone |
5% |
Jan 1, 2021 |
02459698 |
nitisinone 2 mg capsule |
Orfadin® |
5% |
Jan 1, 2021 |
02458624 |
nitisinone 5 mg tablet |
Nitisinone Tablets |
5% |
Jan 1, 2021 |
02457725 |
nitisinone 5 mg capsule |
MDK-Nitisinone |
5% |
Jan 1, 2021 |
02459701 |
nitisinone 5 mg capsule |
Orfadin® |
5% |
Jan 1, 2021 |
02458632 |
nitisinone 10 mg tablet |
Nitisinone Tablets |
5% |
Jan 1, 2021 |
02457733 |
nitisinone 10 mg capsule |
MDK-Nitisinone |
5% |
Jan 1, 2021 |
02459728 |
nitisinone 10 mg capsule |
Orfadin® |
5% |
Jan 1, 2021 |
02470055 |
nitisinone 20 mg capsule |
MDK-Nitisinone |
5% |
Jan 1, 2021 |
02459736 |
nitisinone 20 mg capsule |
Orfadin® |
5% |
Jan 1, 2021 |
02463121 |
obeticholic acid 5 mg tablet |
Ocaliva |
5% |
Oct 30, 2018 |
02463148 |
obeticholic acid 10 mg tablet |
Ocaliva |
5% |
Oct 30, 2018 |
02467224 |
ocrelizumab 30 mg/mL solution for intravenous use (10 mL vial) |
Ocrevus® |
5% |
Aug 10, 2020 |
00839205 |
octreotide acetate 100 mcg/mL ampule |
Sandostatin® |
5% |
Apr 1, 2011 |
02260565 |
omalizumab 150 mg vial |
Xolair® |
5% |
Apr 1, 2011 |
02393751 |
pirfenidone 267 mg capsule |
Esbriet® |
5% |
Apr 12, 2018 |
02464500 |
pirfenidone 801 mg tablet |
Esbriet® |
5% |
Apr 12, 2018 |
02464489 |
pirfenidone 267 mg tablet |
Esbriet® |
5% |
Apr 12, 2018 |
02487454 |
risankizumab 75 mg/0.83 mL pre-filled syringe |
Skyrizi® |
5% |
May 5, 2020 |
02519283 |
risankizumab 150 mg/mL pre-filled syringe |
Skyrizi® | 5% | Oct 18, 2022 |
02519291 |
risankizumab 150 mg/mL pre-filled pen | Skyrizi® | 5% | Oct 18, 2022 |
02532107 |
risankizumab, 600 mg/10 mL single-use vial for intravenous solution | Skyrizi® | 5% | May 30, 2024 |
02532093 |
risankizumab 360 mg/2.4 mL pre-filled, single-use cartridge with on-body injector for subcutaneous injection |
Skyrizi® | 5% | May 30, 2024 |
02241927 |
rituximab 10 mg/mL vial |
Rituxan® |
5% |
Apr 1, 2011 |
02322854 |
romiplostim 250 mcg/0.5 mL powder |
Nplate® |
5% |
Apr 2, 2012 |
02322862 |
romiplostim 500 mcg/mL powder |
Nplate® |
5% |
Apr 2, 2012 |
02388006 |
ruxolitinib 5 mg tablet |
Jakavi® |
5% |
Nov 28, 2023 |
02434814 |
ruxolitinib 10 mg tablet |
Jakavi® |
5% |
Nov 28, 2023 |
02350580 |
sapropterin 100 mg tablet |
Kuvan® |
0% |
Sep 27, 2022 |
02482207 | sapropterin 100 mg sachet | Kuvan® | 0% | Sep 27, 2022 |
02482215 | sapropterin 500 mg sachet | Kuvan® | 0% | Sep 27, 2022 |
02460521 |
sarilumab 150 mg/1.14 mL pre-filled syringe |
Kevzara® |
5% |
June 30, 2020 |
02472961 |
sarilumab 150 mg/1.14 mL pre-filled pen |
Kevzara® |
5% |
June 30, 2020 |
02460548 |
sarilumab 200 mg/1.14 mL pre-filled syringe |
Kevzara® |
5% |
June 30, 2020 |
02472988 |
sarilumab 200 mg/1.14 mL pre-filled pen |
Kevzara® |
5% |
June 30, 2020 |
02499681 |
satralizumab 120 mg/mL pre-filled syringe |
Enspryng® |
0% |
Nov 1, 2023 |
02438070 |
secukinumab 150 mg/mL solution for injection |
Cosentyx® |
5% |
Nov 10, 2016 |
02451158 |
selexipag 200 mcg tablet |
Uptravi® |
5% |
Oct 30, 2018 |
02451166 |
selexipag 400 mcg tablet |
Uptravi® |
5% |
Oct 30, 2018 |
02451174 |
selexipag 600 mcg tablet |
Uptravi® |
5% |
Oct 30, 2018 |
02451182 |
selexipag 800 mcg tablet |
Uptravi® |
5% |
Oct 30, 2018 |
02451190 |
selexipag 1000 mcg tablet |
Uptravi® |
5% |
Oct 30, 2018 |
02451204 |
selexipag 1200 mcg tablet |
Uptravi® |
5% |
Oct 30, 2018 |
02451212 |
selexipag 1400 mcg tablet |
Uptravi® |
5% |
Oct 30, 2018 |
02451220 |
selexipag 1600 mcg tablet |
Uptravi® |
5% |
Oct 30, 2018 |
02416441 |
simeprevir sodium 150 mg capsule |
Galexos™ |
2% |
Mar 1, 2017 |
02436663 |
sodium phenylbutyrate 483 mg/g oral granules |
Pheburane® |
5% |
Apr 12, 2018 |
02418355 |
sofosbuvir 400 mg tablet |
Sovaldi® |
2% |
Mar 1, 2017 |
02456370 |
sofosbuvir-velpatasvir |
Epclusa™ |
2% |
Mar 21, 2017 |
02467542 |
sofosbuvir-velpatasvir-voxilaprevir |
Vosevi™ |
2% |
May 25, 2018 |
02399091 |
somatropin 5 mg/2 mL cartridge |
Nutropin AQ Nuspin 5 |
5% |
Dec 22, 2014 |
02243078 |
somatropin 12 mg cartridge |
Humatrope® |
5% |
Apr 1, 2011 |
02243079 |
somatropin 24 mg cartridge |
Humatrope® |
5% |
Apr 1, 2011 |
02334852 |
somatropin 5 mg/1.5mL pen |
Norditropin Nordiflex® |
5% |
Nov 10, 2016 |
02334860 |
somatropin 10 mg/1.5mL pen |
Norditropin Nordiflex® |
5% |
Nov 10, 2016 |
02334879 |
somatropin 15 mg/1.5mL pen |
Norditropin Nordiflex® |
5% |
Nov 10, 2016 |
02529181 |
somatropin 5 mg/1.5mL pen |
Norditropin® Flexpro™ |
5% |
July 4, 2023 |
02529203 |
somatropin 10 mg/1.5mL pen |
Norditropin® Flexpro™ |
5% |
July 4, 2023 |
02529211 |
somatropin 15 mg/1.5mL pen |
Norditropin® Flexpro™ |
5% |
July 4, 2023 |
02376393 |
somatropin 10 mg/2 mL cartridge |
Nutropin® AQ NuSpin |
5% |
Dec 18, 2012 |
02350149 |
somatropin 20 mg/2 mL cartridge |
Saizen® |
5% |
Apr 2, 2012 |
02399083 |
somatropin 20 mg/2 mL cartridge |
Nutropin® AQ Nuspin 20 |
5% |
Dec 22, 2014 |
02237971 |
somatropin 5 mg vial |
Saizen® |
5% |
Apr 1, 2011 |
02416328 |
teriflunomide 14 mg tablet |
Aubagio® |
5% |
Mar 2, 2015 |
02365154 |
tobramycin 28 mg capsule |
Tobi® Podhaler® |
5% |
Sep 13, 2012 |
02239630 |
tobramycin sulphate 300 mg/5 mL solution for inhalation |
Tobi® |
5% |
Sep 13, 2012 |
02424770 |
tocilizumab 162mg/0.9 mL pre-filled syringe |
Actemra® |
5% |
July 1, 2016 |
02350092 |
tocilizumab 80 mg/4 mL vial |
Actemra® |
5% |
Aug 9, 2011 |
02483327* |
tocilizumab 162 mg/0.9 mL pre-filled syringe autoinjector |
Actemra® |
5% |
Aug 11, 2022 |
02350106 |
tocilizumab 200 mg/10 mL vial |
Actemra® |
5% |
Aug 9, 2011 |
02350114 |
tocilizumab 400 mg/20 mL vial |
Actemra® |
5% |
Aug 9, 2011 |
02423898 |
tofacitinib 5 mg tablet |
Xeljanz® |
5% |
Apr 2, 2017 |
02480786 |
tofacitinib 10 mg tablet |
Xeljanz® |
5% |
Dec 5, 2020 |
02470608 |
tofacitinib 11 mg extended-release tablet |
Xeljanz® XR |
5% |
Dec 5, 2020 |
02246552 |
treprostinil sodium 1 mg/mL vial |
Remodulin® |
5% |
Apr 1, 2011 |
02246553 |
treprostinil sodium 2.5 mg/mL vial |
Remodulin® |
5% |
Apr 2, 2012 |
02246554 |
treprostinil sodium 5 mg/mL vial |
Remodulin® |
5% |
Apr 1, 2011 |
02246555 |
treprostinil sodium 10 mg/mL vial |
Remodulin® |
5% |
Apr 1, 2011 |
02495155 |
upadacitinib 15 mg extended-release tablet |
Rinvoq® |
5% |
Nov 28, 2023 |
02520893 |
upadacitinib 30 mg extended-release tablet |
Rinvoq® |
5% |
Nov 28, 2023 |
02539721 |
upadacitinib 45 mg extended-release tablet | Rinvoq® | 5% | Sept 17, 2024 |
02543036 |
ustekinumab 45 mg/0.5ml pre-filled syringe | Jamteki™ | 5% | June 6, 2024 |
02543044 |
ustekinumab 90 mg/ml pre-filled syringe | Jamteki™ | 5% | June 6, 2024 |
02320673 |
ustekinumab 45 mg/0.5 mL vial |
Stelara® |
5% |
Apr 1, 2011 |
02320681 |
ustekinumab 90 mg/1 mL vial |
Stelara® |
5% |
Jun 20, 2013 |
02550245 |
ustekinumab 45 mg/0.5 mL pre-filled syringe | Steqeyma® | 5% | Sept 17, 2024 |
02550253 |
ustekinumab 90 mg/1.0 mL pre-filled syringe | Steqeyma® | 5% | Sept 17, 2024 |
02550261 |
ustekinumab 130 mg/26 mL intravenous infusion | Steqeyma® | 5% | Sept 17, 2024 |
02544180 |
ustekinumab 45 mg/0.5 mL pre-filled syringe | Wezlana™ | 5% | October 1, 2024 |
02544199 |
ustekinumab 90 mg/1.0 mL pre-filled syringe | Wezlana™ | 5% | October 1, 2024 |
02544202 |
ustekinumab 45 mg/0.5 mL single use vial | Wezlana™ | 5% | October 1, 2024 |
02544210 |
ustekinumab 130 mg/26 mL intravenous infusion | Wezlana™ | 5% | October 1, 2024 |
02436841 |
vedolizumab 300 mg vial |
Entyvio® |
5% |
Aug 24, 2017 |
66123781 |
sodium phenyl butyrate powder |
Buphenyl® |
5% |
Apr 1, 2011 |
DIN/PIN |
Chemical Description |
Product Name |
Effective Date of Deletion |
---|---|---|---|
02527707 |
sodium phenylbutyrate 3 g, ursodoxicoltaurine 1 g / per sachet |
Albrioza™ |
July 19, 2024 |
02452294 |
asunapravir |
Sunpreva™ |
Jan 13, 2018 |
02370816 |
boceprevir 200 mg capsule |
Victrelis™ |
Apr 6, 2016 |
02371448 |
boceprevir/ribavirin/Peg-IFN-alfa-2b |
Victrelis Triple™ |
Apr 6, 2016 |
02371456 |
boceprevir/ribavirin/Peg-IFN-alfa-2b |
Victrelis Triple™ |
Apr 6, 2016 |
02371464 |
boceprevir/ribavirin/Peg-IFN-alfa-2b |
Victrelis Triple™ |
Apr 6, 2016 |
02371472 |
boceprevir/ribavirin/Peg-IFN-alfa-2b |
Victrelis Triple™ |
Apr 6, 2016 |
02386194 |
bosentan 62.5 mg tablet |
Co Bosentan |
Apr 1, 2015 |
02444747 |
daclatasvir 30 mg tablet |
Daklinza™ |
July 29, 2020 |
02444755 |
daclatasvir 60 mg tablet |
Daklinza™ |
July 29, 2020 |
02451131 |
elbasvir-grazoprevir |
Zepatier™ |
Aug 1, 2022 |
02455323 |
etanercept 50 mg/mL syringe |
Brenzys® |
May 1, 2018 |
02455331 |
etanercept 50 mg/mL pen injector |
Brenzys® |
May 1, 2018 |
02436027 |
ombitasvir-paritaprevir-ritonavir and dasabuvir 12.5 mg/75 mg/50 mg and 250 mg tablet |
HOLKIRA™ PAK |
Mar 21, 2017 |
02216191 |
somatropin, kit: 10 mg vial (powder) + 10 mL vial (liquid) |
Nutropin® |
June 30, 2020 |
02229722 |
somatropin 10 mg/2 mL vial |
Nutropin® AQ |
June 30, 2020 |
02230694 |
imiglucerase 200 unit vial |
Cerezyme® |
June 30, 2020 |
02240694 |
interferon alfa-2b 30 million IU recombinant pen injection kit |
Intron A® |
June 30, 2020 |
02240695 |
interferon alfa-2b 60 million IU recombinant pen injection kit |
Intron A® |
June 30, 2020 |
02246026 |
ribavirin/PegIFN-alpha-2b, 200 mg cap/50 mcg/0.5 mL combination pkg |
Pegetron® |
June 30, 2020 |
02246027 |
ribavirin/PegIFN-alpha-2b, 200 mg cap/80 mcg/0.5 mL combination pkg |
Pegetron® |
June 30, 2020 |
02246028 |
ribavirin/PegIFN-alpha-2b, 200 mg cap/100 mcg/0.5 mL combination pkg |
Pegetron® |
June 30, 2020 |
02246029 |
ribavirin/PegIFN-alpha-2b, 200 mg cap/120 mcg/0.5 mL combination pkg |
Pegetron® |
June 30, 2020 |
02246030 |
ribavirin/PegIFN-alpha-2b, 200 mg cap/150 mcg/0.5 mL combination pkg |
Pegetron® |
June 30, 2020 |
02249002 |
somatropin 10 mg/2 mL cartridge |
Nutropin® |
June 30, 2020 |
02253410 |
ribavirin/PegIFN-alpha-2a, 200 mg tablet and 180 mcg/mL combination pkg |
Pegasys® RBV |
June 30, 2020 |
02253429 |
ribavirin/PegIFN-alpha-2a, 200 mg tablet/180 mcg/0.5 mL combination pkg |
Pegasys® RBV |
June 30, 2020 |
02254581 |
ribavirin/PegIFN-alpha-2b, 200 mg cap/80 mcg/0.5 mL pen injection kit |
Pegetron® |
June 30, 2020 |
02254603 |
ribavirin/PegIFN-alpha-2b, 200 mg cap/100 mcg/0.5 mL pen injection kit |
Pegetron® |
June 30, 2020 |
02254638 |
ribavirin/PegIFN-alpha-2b, 200 mg cap/120 mcg/0.5 mL pen injection kit |
Pegetron® |
June 30, 2020 |
02254646 |
ribavirin/PegIFN-alpha-2b, 200 mg cap/150 mcg /0.5 mL pen injection kit |
Pegetron® |
June 30, 2020 |
02272083 |
somatropin 8.8 mg vial |
Saizen® |
June 30, 2020 |